CONTEXT THERAPEUTICS INC (CNTX)
US21077P1084 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 390.67% | N/A 176.22% | N/A 146.85% | ||||||||
| EBITDA YoY % growth | -33.19M | -24.04M 27.57% | N/A | N/A | N/A | -15.37M -43.23% | -25.061M -63.05% | N/A -36.02% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.23M | -24.06M 27.60% | -5.38M | -2.57M 52.23% | -10.53M -309.73% | -15.38M -46.06% | -25.073M -63.02% | N/A -26.42% | N/A 18.05% | N/A -35.73% | N/A -24.18% | N/A -9.26% | N/A 43.19% | N/A 215.66% | N/A 579.19% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | -0.93 90.13% | -1.50 -61.29% | N/A 64.13% | N/A 37.44% | N/A -25.76% | N/A -24.10% | N/A -11.65% | N/A 90.73% | N/A 1,425.89% | N/A 274.98% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 86.24% | -0.06 73.39% | -0.06 -53.00% | -0.07 67.55% | -0.07 -23.52% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.576M 19.58% | -6.12M -60.06% | -6.12M -98.15% | -6.12M 67.28% | -6.12M -9.76% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.22 40.54% | -0.11 | -0.11 | -105.42% |
| Q2 2024 Q2Q % growth | -0.04 87.10% | -0.08 | 0.04 | 47.71% |
| Q1 2024 Q2Q % growth | -0.23 42.50% | -0.45 | 0.22 | 48.75% |
| Q4 2023 Q2Q % growth | -0.42 -90.91% | -0.36 | -0.06 | -17.65% |
| Q3 2023 Q2Q % growth | -0.37 -54.17% | -0.32 | -0.05 | -17.01% |
| Q2 2023 Q2Q % growth | -0.31 -24.00% | -0.20 | -0.11 | -51.96% |
| Q1 2023 Q2Q % growth | -0.40 -81.82% | -0.19 | -0.21 | -106.40% |
| Q4 2022 Q2Q % growth | -0.22 -5.21% | -0.30 | 0.08 | 26.89% |
| Q3 2022 Q2Q % growth | -0.24 | -0.26 | 0.02 | 5.88% |
| Q2 2022 Q2Q % growth | -0.25 | -0.26 | 0.01 | 1.96% |
| Q1 2022 Q2Q % growth | -0.22 | -0.24 | 0.02 | 10.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 71.67% | -53.64% | -88.39% |
| Revenue | N/A | N/A | N/A | N/A |